DOXECITINE
DOXECITINE is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.
Drug Details
- Generic Name
- DOXECITINE
- Brand Names
- N/A
- Application Number
- Sponsor
- ST Pharm Co., Ltd.
- NDC Codes
- 1
- Dosage Forms
- POWDER
- Routes
- N/A
- Active Ingredients
- DOXECITINE
Indications and Usage
1 INDICATIONS AND USAGE KYGEVVI is indicated for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years. KYGEVVI is a combination of doxecitine and doxribtimine, both pyrimidine nucleosides, indicated for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years. ( 1 )